Rhode Peter 4
4 · HCW Biologics Inc. · Filed Dec 11, 2023
Insider Transaction Report
Form 4
Rhode Peter
See Remarks
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-12-11−14,000→ 22,427 totalExercise: $0.14Exp: 2029-12-19→ Common Stock (14,000 underlying) - Exercise/Conversion
Common Stock
2023-12-11$0.14/sh+14,000$1,960→ 77,500 total
Footnotes (1)
- [F1]These option shares were part of a stock option grant covering 85,713 shares of common stock. 20% of the total shares subject to the stock option grant vested on May 30, 2020; 20% of the total shares subject to the stock option grant vested on May 30, 2021; 25% of the total shares subject to the stock option grant vested on May 30, 2022; and 35% of the total shares subject to the stock option grant vested on May 30, 2023, subject to the reporting person's continuous service through the applicable vesting date.